Standard BioTools Inc.

Stocks

Market Closed - Nasdaq 01:30:00 02/09/2026 am IST			5-day change	1st Jan Change
0.6505 ^USD	-1.24%		+0.08%	-49.18%

06/08	Standard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06/08	Standard Biotools Inc. Withdraws Earnings Guidance for the Full Year 2026	CI

Published on 06/09/2026 at 07:51 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you for joining the Standard BioTools and Treeline Biosciences Merger Announcement Conference Call. I would now like to turn the call over to

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

06/08	Standard BioTools Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06/08	Standard Biotools Inc. Withdraws Earnings Guidance for the Full Year 2026	CI
28/07	Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences	MT
28/07	Multiplex BioTech Private Limited agreed to acquire Mass Cytometry Business of Standard BioTools Inc. (NasdaqGS : LAB) for $10 million.	CI
09/06	Standard BioTools Inc. - Special Call
08/06	Standard BioTools, Treeline Biosciences to Merge in All-Stock Deal	MT
08/06	Standard BioTools Regains Compliance With Nasdaq's Minimum Bid Price Requirement	MT
29/05	Standard BioTools - approves 2026 change of control and severance plan on May 21, 2026	RE
07/05	Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024.	CI
06/05	Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/05	Standard Biotools Inc. Reaffirms Earnings Guidance for Fiscal Year 2026	CI
17/03	Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024.	CI
01/03	Standard BioTools Inc.'s Equity Buyback announced on March 1, 2024, has expired with 13,603,617 shares, representing 7.63% for $35.91 million.	CI
25/02	Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
25/02	Standard BioTools Inc. Provides Earnings Guidance for Fiscal Year 2026	CI